Skip to main content
. 2024 Feb 12;22:60. doi: 10.1186/s12951-024-02304-y

Fig. 8.

Fig. 8

Lymphangiogenesis in ischemic tissues after treatment with MSC-EVs in vivo. A Representative immunofluorescence images of gastrocnemius muscle sections harvested from ischemic (I) and non-ischemic limb (N) of vehicle- or MSC-EV-treated mice at 21 days post HLI. B Quantification of Lyve 1 and CD31-stained vessels in tissues of vehicle- or MSC-EV-treated animals. Data are expressed as ratio of ischemic (I) to non-ischemic (N). Student t-test, comparison to vehicle-treated samples (**P < 0.01)